However, further studies are needed to clarify the role of irisin because sarcopenia in these patients has a high incidence and involves infections, hepatic encephalopathies, and longer hospital stays with worsening quality of life and increased health costs. This evidence concerns the gene FNDC5 and sarcopenia.